Subcommittee discusses prioritizing groups under Phase 1B of vaccine allocation

With Pfizer's vaccine making rounds, Moderna's vaccine now authorized for use by the FDA and the CDC issuing new guidance on who should be among the next to receive a COVID-19 vaccine, Wisconsin's State Disaster Medical Advisory Committee's (SDMAC) Vaccine Subcommittee is working to determine how to best offer recommendations on vaccine allocation to the next phase of vaccine recipients.